Treatment of hepatitis C virus infection in kidney transplant recipients: Case report

Transplantation Proceedings

Volumn 43, Issue 1, 2011, Pages 259-262

  Caeiro, F ^a   Baptista, V ^a   Rodrigues, N ^a   Carvalho, D ^a   Aires, I ^a   Remedio F ^a   Nolasco, F ^a  

^a HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; CASE REPORT; CHOLESTATIC HEPATITIS; CONFERENCE PAPER; FEMALE; FIBROSING CHOLESTATIC HEPATITIS; HALF LIFE TIME; HEPATITIS C; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PRIORITY JOURNAL; RECIPIENT; TREATMENT CONTRAINDICATION;

ADULT; ANTIVIRAL AGENTS; BIOPSY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; RIBAVIRIN;

EID: 79951779347     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.001     Document Type: Conference Paper

References (12)

1. Portuguese Society of Nephrology Registry, 2009, www.spnefro.pt
2. Pereira BJ, Natov SN, Bouthot BA, et al: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group, Kidney Int 53:1374, 1998
3. Batty DSJ, Swanson SJ, Kirk AD, et al: Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 1:179, 2001
4. Espinosa M, Martin-Malo A, Alvarez de Lara MA, et al: Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16:1669, 2001
5. Perico N, Cattaneo D, Bikbov B, et al: Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4:207, 2009
6. Fabrizi F, Lunghi G, Dixit V, et al: Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 24:1413, 2006
7. Norah A, Adey D: The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2:563, 2007
8. Davies SE, Portmann BC, O'Grady JG, et al: Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13:150, 1991
9. Delladetsima J, Boletis J, Makris F, et al: Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 5:294, 1999
10. Bustillo E, Ibarrola C, Colina F, et al: Fibrosing cholestatic in hepatitis C virus-infected renal transplant recipients J Am Soc Nephrol 9:1109, 1998
11. Wéclawiack H, Kamar N, Meherenberger M, et al: Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts. Nephrol Dial Transplant 23:1043, 2008
12. Viral hepatitis guidelines in hemodialysis and transplantation. Am J Transplant 4:72-82, 2004